Cytodyn Inc 's ROA from the fourth quarter of 2026 to the fourth quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Cytodyn Inc 's ROA in the fourth quarter of 2026?
Cytodyn Inc recorded a cumulative net loss of $-43 million during 12 months ending in the fourth quarter of 2026, resulting in a negative return on assets (ROA) of -266.87%.

However, within the Healthcare sector 881 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the May 31 2026 quarter, so far to 4519, from total ROA ranking in the third quarter of 2026 at 5220.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(May 31 2026) IV. Quarter	(Feb 28 2026) III. Quarter	(Nov 30 2025) II. Quarter	(Aug 31 2025) I. Quarter	(May 31 2025) IV. Quarter
Y / Y Total Assets Change	-22.57 %	-12.71 %	307.2 %	-51.88 %	307.2 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-43	-39	-39	-21	4
Return On Assets (TTM)	-266.87 %	-227.95 %	-219.65 %	-147.13 %	20.9 %
CYDY's Total Ranking	# 4519	# 5220	# 4476	# 256	# 4018
Total Assets (TTM) in million	14	18	18	13	18
Seq. Total Assets Change	-24.46 %	2.49 %	33.85 %	-25.29 %	-14.84 %
Seq. Net Income Change	-	-	-	-	-

CYDY's 5 Years Annual ROA >> Back to CYDY Management Effectiveness >> Compare CYDY ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 422
Sector	# 882
Overall	# 4498

Return On Assets Statistics
High	Average	Low
19.11 %	-344.96 %	-830.46 %
(May 31 2025)		(Nov 30 2018)

Financial Statements
Cytodyn Inc 's Assets	$ 14 million	CYDY's Balance sheet
Cytodyn Inc 's Income	$ -10 million	Quarterly CYDY's Income Statement
CYDY's Income by Division		See CYDY's Income by Division

Annual Return On Assets	(May 31 2026) FY 2026	(May 31 2025) FY 2025	(May 31 2024) FY 2024	(May 31 2023) FY 2023	(May 31 2022) FY 2022
Y / Y Total Assets Change	29.64 %	307.2 %	-7.38 %	-83.6 %	-77.9 %
Total Assets in million	23	18	4	5	29
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-43	4	-50	-80	-211
Annual Return On Assets	-182.5 %	20.75 %	-1124.57 %	-1668.21 %	-722.36 %

CYDY's 5 Years Annual ROA >> Back to CYDY Management Effectiveness >> Compare CYDY ROA to its Competitors

More Return On Assets Ratios
CYDY's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CYDY's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CYDY's Competitors
Subscribers only: Roa for Cytodyn Inc 's Suppliers
Subscribers only: Return On Assets for CYDY's Customers

You may also want to know
CYDY's Roi	CYDY's Inventory Turnover Ratio	CYDY's Growth Rates	CYDY's Dividend Comparisons
	CYDY's Profitability Ratios	CYDY's Asset Turnover Ratio	CYDY's Dividend Growth
CYDY's Roe	CYDY's Valuation Ratios	CYDY's Financial Strength Ratios	CYDY's Dividend Payout Ratio

Companies with similar Return On Assets at May 31 2026, within Healthcare Sector

ROA

Date modified: 2026-09-05T08:54:17+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.